Help and support
For explanations of financial products, disclosures and our consumer duty requirements.
Product governance
This page is intended for third-party distributors and intermediaries. It provides information on our MiFID II product governance process, target market and distribution strategy, together with our costs and charges and data disclosures. These documents are strictly for information purposes and should not be considered as an offer, investment recommendation or solicitation to deal in any of the investments mentioned and does not constitute investment research. The templates include all funds even if they are not registered in a particular jurisdiction.
MiFID II (EMT) Templates
Here, you can find the European MiFID templates – key documents which explain the features of investment products, including the risks and costs involved.
EMT information is updated monthly. Please send any queries relating to the templates to RegulatoryDataTeam@bailliegifford.com
Costs and charges summary
As a firm, we understand the need for greater transparency of costs and charges to allow investors to undertake a value assessment, which will drive competitive pressure, leading to increased efficiency and improved competitiveness of the market.
We recognise that with various disclosure obligations on cost transparency (both under UK and European regulations), it is important for investors to have full visibility of costs and charges within the product that they have chosen to invest in.
New product approval process
Our new product approval process provides information about our three-phase product lifecycle for new fund launches and includes our MiFID II target market assessment disclosure.
Please send distributor feedback to distributionservices@bailliegifford.com
Important information
The information provided does not constitute an offer of or solicitation for purchase or sale of securities or provision of any investment services. Baillie Gifford does not currently have any funds that offer securities under a simplified prospectus for general offer or sale within Canada. No securities regulatory authority in Canada has reviewed or in any way passed upon this website or the merits of any investment available, and any representation to the contrary is an offence.
Persons resident or domiciled in Canada should consult with their professional advisers as to whether they require any governmental or other consents in order to enable them to trade.
You can read details of our Legal and Important Information here.
Trade Matching Statement
This Trade-Matching Statement is being provided in accordance with National Instrument 24-101 -"Institutional Trade Matching and Settlement" and Companion Policy 24-101 CP (the "National
Instrument"). It applies to all trades that are subject to the National Instrument. View the whole statement.
Important disclosures
For important disclosures, best execution and trading disclosures, modern slavery statements, and privacy notices.